samedan logo
 
 
 
spacer
home > ebr > autumn 2020 > mesenchymal stem cells: the next generation of pain treatments
PUBLICATIONS
European Biopharmaceutical Review

Mesenchymal Stem Cells: The Next Generation of Pain Treatments

Pain is a major burden of disease and will likely increase as populations around the world grow older and the incidence of obesity increases.

The global market for pain therapies is large and growing, and is expected to be worth $77 billion by 2023 (1). Treatments for osteoarthritis alone will constitute a $10.1 billion market by 2024 (2).

However, pain is notoriously hard to treat and chronic pain – pain from diseases such as osteoarthritis, general knee, and back pain – even more so. Current treatment options for pain – often opioids or surgery – mostly treat the symptoms, not the source of the pain.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Leo Lee, CEO of Regeneus, is a Senior Executive with over 20 years of experience in pharmaceutical innovation, commercialisation, regulatory and policy. He has worked in North America, Asia, and has lived and worked in Japan the last 12 years. Leo was previously President of Allergan, Japan, and former President of Merck, Japan.
spacer
Leo Lee
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

SEKISUI XenoTech Receives New US Patent for a Method to Evaluate Xenobiotics as Immune-Modulators of Drug Transport and Metabolism in Hepatocytes

Kansas City, KS- SEKISUI XenoTech has been awarded US patent # 10,648,968 “In vitro test system to evaluate xenobiotics as immune-modulators of drug transport and metabolism in human hepatocytes.”
More info >>

White Papers

Exploring Protein Stability by nanoDSF

NanoTemper Technologies GmbH

nanoDSF determines thermal and chemical protein stability with ultra-high resolution and with unmatched reproducibility. The detection of the intrinsic tryptophan and tyrosin fluorescence enables measurements at close-to-native conditions in any buffer, even in the presence of detergents. nanoDSF is applied in antibody engineering, membrane protein research, formulation and quality control.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement